Prevalence, incidence and duration

American Journal of Epidemiology
J Freeman, G B Hutchison

Abstract

Prevalence, incidence and duration of a condition or illness in a steady-state population are interrelated in such a way that two of these quantities may be used to obtain the third. Data may be collected in the most expedient manner, either as prevalence or incidence series of cases, and the results expressed as both incidence and prevalence. Information about the distribution of total durations of the condition in an incidence series of cases, or about the distribution of total durations or durations-to-date in a prevalence series is necessary in order to use these relations between prevalence and incidence of a condition or illness. The duration of a condition may be taken as one measure of the effect of the condition or illness on a population, and a "treatment effect" measured by comparing two populations may be termed the etiologic duration. Exact methods are presented for interconverting the distribution of total durations of condition among prevalence and incidence series of cases arising from the same steady-state population. Both prevalence and incidence series of cases may naturally arise in the same epidemiologic study, such as the initiation and conduct of a periodic screening program, and under certain conditions ...Continue Reading

Citations

Jul 11, 1991·The New England Journal of Medicine·J C WeeksM C Weinstein
Jan 1, 1996·Journal of Medical Screening·J F BoivinC Archer
Aug 31, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J W WeinsteinW J Hierholzer
Aug 18, 1999·Occupational and Environmental Medicine·C NordanderS Skerfving
May 4, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jose Rossello-Urgell, Alicia Rodriguez-Pla
Apr 14, 2005·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·J S SlokaM Stefanelli
Jan 26, 2007·Critical Care Medicine·Rachel S Bensen, Thomas Bojko
Jul 26, 2012·The Journal of Infectious Diseases·Osman AbdullahiJ Anthony G Scott
Jan 11, 2013·American Journal of Epidemiology·Ron BrookmeyerSusan H Eshleman
Oct 20, 2015·Bulletin of the World Health Organization·Yuko KumagaiKenji Shibuya
Dec 17, 2015·The Australian and New Zealand Journal of Psychiatry·Svein Reidar KjosavikElisabeth E Roughead
Feb 15, 2017·The Australian and New Zealand Journal of Psychiatry·Svein R KjosavikElisabeth E Roughead
Aug 30, 2018·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Iman FakihUNKNOWN for SPIN-BACTOT
Jan 27, 2019·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Mohsen SadatsafaviUNKNOWN Canadian Respiratory Research Network
Jul 23, 1999·Sexually Transmitted Diseases·S L GrosecloseM E St Louis
Dec 25, 2002·Epidemiology·Alfredo NicolosiCarlo Giaquinto
Feb 24, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·P GastmeierH Rüden
Jun 4, 2002·Human Reproduction·Krina T ZondervanStephen H Kennedy
Apr 1, 2009·PLoS Neglected Tropical Diseases·Nicolas PraetStanny Geerts
Feb 3, 2007·Journal of Chemotherapy·S FariaUNKNOWN Prevalence Study Group
Oct 15, 2009·International Journal of Environmental Research and Public Health·Yuejen Zhao, Rosalyn Malyon
Jul 12, 2013·Biometrika·Marco CaroneMei-Cheng Wang
Oct 1, 2016·Intensive Care Medicine·UNKNOWN SepNet Critical Care Trials Group
Aug 25, 2015·Biometrics·Jacob Konikoff, Ron Brookmeyer
Nov 7, 2017·Statistical Methods in Medical Research·Gabriel Isheden, Keith Humphreys
May 5, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Gregg S GonsalvesEdward H Kaplan
Nov 12, 2010·European Journal of Ageing·Luisa FrovaAlessandra Battisti
Oct 10, 2019·The Australian and New Zealand Journal of Psychiatry·Dae Jong OhKi Woong Kim
Feb 1, 1994·Occupational and Environmental Medicine·U Strömberg
Jan 1, 1989·Genetic Epidemiology·L E MarksonR Brookmeyer
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·M LipsitchB R Levin
Oct 1, 2005·Acta Oto-laryngologica·J J Pérez-LázaroE Navarro
Dec 1, 1994·Occupational and Environmental Medicine·K OhlssonS Skerfving
Oct 31, 2001·AIDS·A SabbatiniUNKNOWN Northern Italian Seronegative Drug Addicts (NISDA) study
Dec 15, 2006·Critical Care Medicine·Elisheva SimchenInbal Weiss-Salz
May 23, 2012·Transfusion·J C Enticott, R K Kandane-Rathnayake
May 7, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Walter ZinggDidier Pittet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.